Patty Wingeris the Founder and President of Collaborative Clinical Research Solutions (CCRS Consultants) supporting academia and hospital systems navigate the complexities of multi-institutional research collaborations. With a proven record of achievement spanning 25 years in clinical research operations and network management, Patty offers excellent strategic insight and leadership skills to the University of Texas System Initiative, Clinical Trials Xpress. Patty previously served as Vice President and Chief Operating Officer of the Statewide Clinical Trials Network of Texas; Vice President of Business Integration at Sarah Cannon Research Institute; and Vice President of Research Operations at US Oncology.
Tiffany L. Israel, MSSW, is the Community Navigator for the Vanderbilt Institute for Clinical and Translational Research. In this role, Tiffany manages the Community Engagement Studio, a nationally recognized model that creates dialogue between academic researchers and community members to improve the quality of research being conducted and the likelihood of wider dissemination. She is also an Instructor for the Vanderbilt Medical School focusing on patient engagement and community healthcare factors. Tiffany supports the development of community engaged research by conducting institutional seminars and frequently guest lectures and conducts training focused on best practices for patient engagement and addressing social determinants of health. Prior to joining Vanderbilt, Ms. Israel, a trained facilitator, gained more than 15 years of experience working in and with the Nashville community most recently as the Director of Programs and Resource Development for the Neighborhoods Resource Center and the Associate Executive Director for St. Luke’s Community House and Family Resource Center. Tiffany’s has a Master’s degree in Social Work and Community Practice from the University of Tennessee and a Bachelors of Social Work from Middle Tennessee State University.
Zain Kazmi, MBA is the Assistant Vice Chancellor and Chief Analytics Officer for Health Affairs at The University of Texas System. He serves as the Program Sponsor of the UT-Health Intelligence Platform (UT-HIP). UT-HIP is a data and analytics platform that serves the data needs and objectives of the Chancellor’s Health Care Enterprise Quantum Leap. Kazmi was previously a management consulting executive in Accenture’s Digital Health practice. He has extensive experience in developing and formulating thorough analytics strategies and leading implementations across several leading health systems. Additionally, Kazmi was appointed as the Vice Chair of the Board of Directors for International Child Care, a non-profit healthcare system in Haiti and Dominican Republic. Kazmi earned his Master of Business Administration with a focus on healthcare and strategy from the University of Michigan Ross School of Business.
Robert Murphy, MD serves as the acting Director of UT-Health Intelligence Platform (UT-HIP), a data and analytics platform that serves the data needs/objectives of the Chancellor’s Health Care Enterprise Quantum Leap. Dr. Murphy joined the full time faculty of the School of Biomedical Informatics at UT Houston in 2015 after serving as adjunct faculty since 2005 when he was named Chief Medical Informatics Officer at Memorial Hermann Healthcare System. At Memorial Hermann, Dr. Murphy provided system-wide leadership on clinical information system projects. He has published and lectured widely on physician adoption and change management, development of evidence-based content for electronic health records and using information technology to improve patient safety and quality. Modern Healthcare Magazine named Dr. Murphy one of the nation’s Top 25 Clinical Informaticists in 2010, 2011 and 2012. Dr. Murphy was board certified in Emergency Medicine through 2013, and completed his residency in emergency medicine at Henry Ford Hospital in Detroit. He graduated from the University of Kentucky College of Medicine after finishing his undergraduate work with a B.A. in History at Rice University in Houston.
Laura J. Yearsley, MsC is the Research Programs Manager at Vanderbilt Institute for Clinical and Translational Research. Laura heads up the Recruitment Innovation Center (RIC) team. As well as managing the RIC team at Vanderbilt, Laura also works across 4 partner institutions that are also involved in the RIC. These include; The Ohio State University, Colombia University, Rockefeller University and the University of Utah. She also works closely with Drs Paul and Consuelo Wilkins who are the co-PIs on the RIC grant and who together, bring important expertise around community engagement and health informatics. Laura moved over to the US from the UK in June this year and has been at Vanderbilt for 8 months. Laura's background is in UK health policy, research and advocacy. She previously worked at a senior level in government, advising the Health Service Ombudsman. She authored reports and choreographed parliamentary inquiries on complex areas of public policy such as end of life care and sepsis. Prior to this, she worked for the MS Society for 8 years and as Head of Policy and Campaigns, helped establish the first MS register, spearheaded two award winning networks which helped recruit both campaigners and people who were interested in getting involved in research, and during this time, worked with the neurological community to improve access to MS medicines. She also chaired a group that supported over 80 patient organizations to better engage with a regulatory body that determined what treatments should be provided on the NHS. She has an MSc in Public Policy from University College London and a degree in Politics from the University of York.
Sue Fisher-Hoch, MD graduated First Class from the Royal Free Hospital School of Medicine being awarded the Elizabeth Garrett Anderson fellowship. She then gained a Masters’ degree in Medical Microbiology, membership of the Royal College of Pathology (Boards) specializing in virology and a doctoral degree in epidemiology (MD). Her doctoral thesis findings published in the Lancet reported the first isolation of Legionella pneumophila from a patient, and the first identification of hot water systems as the source. She also at this time discovered the role of parvovirus B19 as the causative agent of Fifth’s Disease (slapped check syndrome). In 1986 she was recruited to CDC, Atlanta, where she studied the pathophysiology of Ebola and Lassa viruses in non-human primates and patients and developed vaccines, traveling widely to Africa and Asia conducting epidemiological studies. In 1992 she moved to Karachi where she published studies on tuberculosis and Congo Crimean Hemorrhagic Fever among several studies. In the late 1990a she designed the French BSL4 space suit laboratory, and was awarded the Légion d’Honneur by the President of France. Since 2001 she has worked in Brownsville, south Texas, establishing an extensively documented minority cohort making major advances in understanding of diabetes and its many complications and risk factors in minority populations. She now directs this Cameron County Hispanic Cohort; a population based Mexican American Cohort numbering 4,500 individuals followed up regularly. This cohort is the focus of multiple collaborations with institutes across Texas and the United States, including MD Anderson, the McGovern School of Medicine, Baylor College of Medicine and many others, In 2016 the cohort was the basis of a Program Grant proposal at the invitation of the NCI. She has published a total of about 200 papers with several more in preparation.
Lisa R. Treviño, PhD, joined Doctors Hospital at Renaissance January 2014 as Vice President of Research and Development. Dr. Trevino earned a doctorate in Molecular, Cellular and Development Biology from the University of California at Santa Cruz and did her postdoctoral training at St. Jude Children’s Research Hospital in Memphis, TN., focusing on the pharmacogenomics of children with Acute Lymphocytic Leukemia. Prior to moving back home to the Rio Grande Valley, Dr. Trevino was serving as scientific analyst and project manager for various adult and pediatric cancer projects at the Human Genome Sequencing Center at Baylor College of Medicine in Houston, TX. Her research efforts have contributed to the understanding of how different types of mutations in our DNA are involved with the way in which individuals respond to various medications and how changes in our DNA may cause different disease like cancer and diabetes. With her extensive basic and translational research experience, Dr. Trevino has published in top-tiered, peer-reviewed scientific journals including Nature and Science and other prominent cancer journals. Dr. Trevino will lead the research program at DHR by helping to expand the current clinical research portfolio which includes clinical trials in the areas of Diabetes, Oncology, Cardiology and Women’s and Men’s Health and other diseases. Similarly, Dr. Trevino and her research staff will help facilitate research collaborations and partnerships with academic institutions, pharmaceutical industry as well as aid in Investigator-initiated research at Doctors Hospital at Renaissance. Throughout her scientific career, Dr. Trevino has established and maintained professional collaborations with the experts in the fields of Genetics, Genomics and Bioinformatics at the Texas Medical Center as well as with other institutions nation-wide and will work tirelessly to bring the most cutting-edge technology and advanced diagnostics to DHR and the people of the Rio Grande Valley.
Paula Shireman, MD, MS is a Professor in the departments of Vascular and Endovascular Surgery with a secondary appointment in Microbiology & Immunology at the University of Texas Health San Antonio. She is an academic vascular surgeon and basic/translational science researcher and holds the Dielmann Chair in Surgery endowment. In her clinical role, she performs open and endovascular procedures while training residents and medical students. She serves as the Scientific Advisor for Clinical Trials Xpress, the University of Texas System centralized clinical trials office. As a researcher, she is the principal investigator for grants from the National Institutes of Health and the Veterans Administration. Her published research is primarily in macrophage biology, angiogenesis, stem cells, tissue regeneration and microRNAs. Her translational research incorporates medical, graduate and postdoctoral student training. She collaborates with investigators at the San Antonio Military Health System to determine the long- term outcomes of Service Members with extremity vascular injuries to improve battlefield treatments and transitions of care between the Department of Defense and Veterans Administration. Dr. Shireman’s publications can be viewed using this link. Dr. Shireman is the Co-Principal Investigator of the Institutional Clinical Translational Science Award (CTSA) responsible for strategic partnership with CTSA-affiliated institutions, biostatistics, study design and biomedical informatics cores, and evaluation of all CTSA programs, incorporating Six Sigma Lean Methods to improve efficiencies. Dr. Shireman has been active in the development of CTX central operations. She has extensive experience in team building, research and administration. Dr. Shireman has presented on two panels for the Institute of Medicine regarding sharing clinical trial data.
Ellyn Getz is the Senior Manager of Development and Community Engagement at CISCRP, a nonprofit organization dedicated to engaging the public and patients as partners in the clinical research process. She is responsible for directing CISCRP’s educational and outreach initiatives, including AWARE for All: Clinical Research Education Days, Amplifying the Patient Voice and Perceptions & Insights roundtable discussions, Patient Advisory Panels, and the Medical Heroes Appreciation 5K events. Prior to joining CISCRP, Ellyn worked at College of the Atlantic as a Conference and Event s Coordinator and at Brandeis University where she worked in alumni relations coordinating reunion events and development efforts. Ellyn holds a BA in Business Administration and Theatre Arts, highest honors summa cum laude, from Brandeis University.
Clinical Trials Xpress brought together academic and industry experts for a 2-day symposium to discuss trends, critical challenges, and innovative technical solutions and platforms for patient recruitment and enrollment planning in multicenter Network clinical trials.
Robert Toto, MD is the Mary M. Conroy Professor of Kidney Disease in UT Southwestern’s Department of Internal Medicine. He specializes in kidney disease treatment and research. Dr. Toto also is the Associate Dean of Clinical and Translational Research in the Graduate School of Biomedical Sciences; the Director of the Center for Translational Medicine; and the Medical Director of UT Southwestern’s Multi-Specialty Clinic. Dr. Toto earned his medical degree at the University of Illinois Medical School. He completed a residency in internal medicine at the University of Michigan and Baylor College of Medicine and then received advanced training in nephrology through fellowships at the U.S. Public Health Service Hospital and UT Southwestern Medical Center. He joined the UT Southwestern faculty in 1983. Dr. Toto has been named a D Magazine Best Doctor for nephrology and hypertension every year since 2009 and is a Texas Monthly Super Doctor. He is nationally and internationally known for clinical research and teaching. He has been awarded numerous teaching awards from medical students and residents at UT Southwestern and is a regular speaker at national and international nephrology meetings on a variety of topics in renal disease. He has served on program committees for the American Society of Nephrology, the International Congress of Nephrology, and the National Kidney Foundation and is actively involved with training and research policy development at the national level through the American Society of Nephrology and the National Institutes of Health. Dr. Toto’s research interests include detection, prevention, and treatment of progressive kidney diseases, including diabetes and hypertension. He has an active laboratory and has been intimately involved in the design and conduct of phase I clinical trials as well as several major outcomes trials in patients with chronic kidney disease, including NIH- and non-federally funded trials (e.g., the AASK trial, the HEMO study, and TREAT). He has authored more than 100 original articles and textbook chapters related to diagnosis and management of hypertension and kidney diseases. His published work includes pathophysiology of hypertensive and diabetic renal diseases, dyslipidemia in chronic kidney disease, novel risk factors for diabetic nephropathy, anemia in patients with chronic kidney disease and dialysis-related morbidity and mortality, and other complications of kidney disease. In addition, he has served on the editorial boards of Kidney International, Journal of the American Society of Nephrology, American Journal of Kidney Disease and Nephrology, American Journal of Nephrology, Nephrology Dialysis and Transplantation, and Current Opinion in Nephrology and Hypertension.
Heath Goodrum joined the Biomedical Informatics Group in 2015 after receiving his bachelor’s in Computer Science from Sam Houston State University. As a junior programmer he participated in the development and support of BIGTxt, moving on to a lead programmer role in the design and implementation of UTP’s Chronic Disease Registry. In addition to providing on-going support for existing applications, he is responsible for leading the team developing the Sickle Cell Registry.
John McIlwain, MBA is co-founder, Chairman of the Board and CEO of Velos, Inc based in Fremont California. Prior to Velos, he was co-founder and President of Aithent, based in New York City, which he grew at Inc 500 rates from 1992 to 1996 before starting Velos with his business partners. Aithent is a software development services and products company focused on financial services and healthcare. For several years during his Aithent tenure, John was an Adjunct Professor of Computer Science at Columbia Business School. Prior to Aithent, he was a market analyst at Sun Microsystems. Before Sun, from 1986 to 1989, he was a Senior Consultant in the Professional Services Group of Price Waterhouse in New York City. John has an MBA in Finance and Marketing from Columbia Business School in New York City, and BA in English and Economics from Middlebury College in Middlebury, Vermont. In addition to Velos, he serves on the Boards of StafaCT, Inc. and 121st Street Partners, LLC.
Kate Wilkinson, MS, is the manager of the recruitment office at UT Southwestern and also the project manager for the Dallas Heart Study, a longitudinal study of 6000 residents of Dallas County. She is the responsible for day to day operations of the UTSW Volunteer Research Registry and also serves as the local Patient Engagement Officer for UT Southwestern for the Greater Plains Collaborative Clinical Research Data Network (PCORI). Before coming to UT Southwestern, she worked at NIH/NIAID in clinical research affairs for the Division of Microbiology and Infectious Diseases and the Division of AIDS.
Mark Hogendobler is the Austin-based North American Director for TriNetX, Inc. He has worked in Healthcare IT for the past twenty years, with experience in Cardiology and Radiology Information Systems and PACS, structured reporting, and electronic health record interoperability. He has been at TriNetX since 2014, and has recently be promoted to manage expansion to Canada and Latin America. He has a degree from Princeton University in Molecular Biology.
Lena Swander, MPH joined the Institute for Clinical and Translational Science (ICTS), the University of Iowa CTSA, in 2015 as the Greater Plains Collaborative network program manager for the ADAPTABLE Aspirin Trial, a PCORI demonstration project. She also serves as ICTS’ Evaluation Core Manager and Common Metrics project leader. Her primary academic interests include preventive healthcare, chronic disease comparative effectiveness research, and programmatic evaluation.
Joseph McCormick, MDis the Regional Dean, Brownsville campus of the University of Texas School of Public Health. Over the past 44 years of his career, Dr. McCormick has traveled the globe investigating disease outbreaks and making significant contributions to the field of medicine. His investigations have included the meningococcal meningitis outbreaks in Brazil (1974-76), the Ebola epidemic in the Congo (1976) and in Sudan (1979), and Lassa hemorrhagic fever in Sierra Leone (1976-79). Dr. McCormick also became involved in the study of HIV/AIDS in Africa helping establish a key point in the natural history of HIV infection in Africa. His work in HIV/AIDS continued with the Centers for Disease Control and the World Health Organization. At the UTSPH in Brownsville, he has worked to establish the first Hispanic Health Research Center, funded by the NIH and focuses on the health issues of Hispanic people which has led to the development of a strong research program focused on the health issues of the Lower Rio Grande Valley people. Dr. McCormick conducts research under NIH, CTSA, CDC grants and has over 250 scientific publications with co-authors from over 20 different countries.